JVJosé Carlos Esteves Veiga

José Carlos Esteves Veiga

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


José Carlos Esteves Veiga has a total of 80 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Decompressive craniectomy in children and adolescents with severe traumatic brain injury: a systematic review.

    by Jose Roberto Tude Melo, Caio Vinicius De Almeida Chaves, Júlia Calviello Giordano, Luíza Malheiros Montagna, Henderson Rhavi De Jesus Luz, Paula De Almeida Azi, Jean Gonçalves De Oliveira, José Carlos Esteves Veiga

    Introduction/Background: Decompressive craniectomy (DC) is a neurosurgical technique employed in pediatric patients with severe traumatic brain injury (sTBI). However, consensus remains lacking regarding the specific criteria for its indication. The objective of this study is to synthesize data concerning the clinical and CT scan criteria for performing DC in children and adolescents with sTBI. Methodology: This systematic review analyzed scientific studies indexed in the MEDLINE database via the PubMed platform. The search included studies published between 2015 and 2025 that involved children and adolescents (under 18 years of age) with sTBI treated with DC. This review is registered in the International Prospective Register of Systematic Reviews (PROSPERO: CRD420251159406). Results: Eighteen manuscripts describing the clinical and tomographic criteria for DC indication were included. In a combined sample of 916 children, pupillary abnormalities (162/343; 47.2%) were identified as a primary clinical factor guiding surgical decisions. CT imaging revealed post-traumatic intracranial mass lesions associated with midline shift (MLS), further justifying the procedure. Invasive intracranial pressure monitoring (ICPm) was utilized in 48.6% (386/794) of cases, and the overall mortality rate was 24% (220/916). Conclusion: In children and adolescents victims of sTBI, pupillary abnormalities coupled with CT evidence of acute intracranial lesions, mass effect, and MLS are key indicators for DC, whether or not invasive ICPm is employed.

  • Open Access

    Past, Present and Future of the Treatment of Traumatic Brain Injury in Children and Adolescents

    by José Carlos Esteves Veiga, Jose Roberto Tude Melo

    Historical Background The first clinical evidence of Traumatic Brain Injury (TBI) was discovered in prehistoric Tanzania, with findings dating back to approximately 2 million years BC in the pre-historic period, in Tanzania, apparently due to a crocodile bite demonstrating cranial fractures [1]. The earliest written records appear in the Edwin Smith Papyrus (Ancient Egypt, ~3000–2500 BC), which described head injuries, skull fractures, and neurological symptoms, establishing the first known classification of TBI severity. There were 27 head injury cases of which 13 were fractures with neurological involvement. The Edwin Smith Papyrus is still preserved at the New York Academy of Medicine in New York City [1,2]. The recognition that children require distinct treatment from adults is a much more recent achievement. Initially based solely on the presence or absence of skull fractures, later shifting toward the neurological deficits observed. For centuries, injured children were treated merely as "small adults," with identical therapeutic approaches and no recognition of the physiological peculiarities of the developing brain [3,4]. Historically, the lack of pediatric-specific protocols was one of the greatest challenges in caring for children with TBI. Decisions on performing CT scans or invasive intracranial pressure (ICP) monitoring were based on extrapolations from adult studies, which often led to unnecessary radiation exposure in children or, on the other hand, delayed diagnosis of intracranial lesions. Furthermore, the absence of evidence-based guidelines for the pediatric ICU meant that practices such as deep sedation, hyperventilation, and barbiturate coma therapy were used inconsistently, with significant variation among institutions and a lack of clear target parameters [4,5,6]. Present In the present, specific protocols have transformed pediatric neurotrauma care. The PECARN (Pediatric Emergency Care Applied Research Network) [7] rule represents a milestone: a rigorously validated clinical decision rule that allows clinicians to safely identify children at low risk of clinically significant TBI, avoiding unnecessary CT scans and their associated radiation. Developed from a large multicenter cohort (over 42,000 children), the PECARN rule has high sensitivity and an excellent negative predictive value, substantially reducing radiation exposure in the pediatric population [7]. In the ICU setting, the publication of evidence-based guidelines, such as those from the Brain Trauma Foundation [8], standardized the management of severe pediatric TBI. Current recommendations encompass multimodal neuromonitoring (ICP, brain tissue oxygenation — PbtO2, and continuous electroencephalography), strict thermal control, maintenance of adequate cerebral perfusion pressure (CPP) with age-adjusted targets, hyperosmolar therapy (mannitol), and, in selected cases, decompressive craniectomy. The recognition that the immature brain has a distinct neurometabolic cascade post-trauma including prolonged ionic flux, mitochondrial dysfunction, and increased vulnerability to excitotoxicity has also driven the development of age-appropriate neuroprotective strategies [4,5,8]. FUTURE The future focuses on Precision Medicine, with the integration of serum and neuroimaging biomarkers aimed at personalized diagnosis and prognosis [9,10]. Biomarkers such as GFAP (Glial Fibrillary Acidic Protein), UCH-L1 (Ubiquitin C-terminal Hydrolase L1), NfL (Neurofilament Light Chain), and a panel of inflammatory cytokines are being validated to stratify lesion severity, predict outcome, and guide therapeutic decisions without relying exclusively on clinical and conventional imaging criteria. Together with advances in genomics and pharmacogenomics, the goal is to develop individualized neuroprotective drugs that modulate specific pathways — such as the neuroinflammatory cascade, oxidative stress, and apoptosis — in a manner tailored to each patient's genetic profile [3,9,10]. Artificial Intelligence (AI) — particularly Machine Learning algorithms — emerges as a transformative tool. Predictive models fed by continuous ICP, PbtO2, and multimodal hemodynamic data are being developed for real-time monitoring, capable of anticipating episodes of intracranial hypertension and cerebral hypoperfusion minutes before they occur, enabling proactive rather than merely reactive interventions [8,9]. Differences Between the Infant and Adolescent Brain Identifying the pathophysiological differences of TBI between infants and adolescents is essential for appropriate clinical management. At the extremes of childhood, the cranial and cerebral characteristics are profoundly distinct, directly influencing the response to trauma. The Brain and Skull of the Infant (0 to 2 Years) [3,4,6] Cranial Compliance: The infant's skull has open fontanelles and non-fused sutures, providing a natural expansibility that can mask classic signs of intracranial hypertension for longer periods. Paradoxically, this same compliance makes the brain more vulnerable to contrecoup injuries and parenchymal deformation during impacts. Trauma Mechanics: The disproportionately large head relative to the body, combined with weak cervical musculature, predisposes infants to high-energy acceleration-deceleration injuries (angular acceleration), such as those seen in abusive head trauma (shaken baby syndrome). The immature, highly aqueous brain (with reduced myelin) undergoes greater deformation under shear stress. Vulnerability to Hypovolemia: The total blood volume in an infant is significantly lower in absolute terms compared to adolescents. Intracranial hemorrhage or even extensive subgaleal hematomas can rapidly lead to hypovolemic shock — a phenomenon rarely seen in older children or adults after an isolated head injury. The Brain and Skull of the Adolescent Monro-Kellie Doctrine: the skull becomes a rigid, non-expandable...

  • Open Access

    Assessment of venous thromboembolism in adult-type diffuse gliomas at a quaternary neuro-oncology center: a retrospective cross-sectional study and systematic review

    by Leonardo de Sousa Bernardes, Lucas de Oliveira Woehl, Jean Gonçalves de Oliveira, José Carlos Esteves Veiga, João Luiz Vitorino Araujo

    Venous thromboembolism (VTE) remains a clinically relevant and impactful complication in patients with adult-type diffuse gliomas, and its overall frequency and determinants remain poorly defined. We retrospectively examined 147 patients with gliomas treated at a Brazilian quaternary neuro-oncology center during 2018–2023 and performed a Preferred Reporting Items for Systematic Reviews and Meta-Analysis/Synthesis without Meta-Analysis–based systematic review of observational studies (incorporating eight cohorts; N = 7779) published since 2015. The patients’ median age at diagnosis was 55 (range 20–86) years. Glioblastoma was the predominant glioma type ( n = 91, 61.9%), followed by astrocytoma ( n = 32, 21.8%) and oligodendroglioma ( n = 24, 16.3%). VTE events occurred in 5 (3.4%) patients, 4 (80%) with isocitrate dehydrogenase (IDH)–wild-type glioblastoma (5.6% incidence within this subgroup) and 1 (20%) with IDH-mutant astrocytoma; no thrombosis was identified in patients with oligodendrogliomas. All five events (three pulmonary thromboembolism [PTE] and two lower-limb deep-vein thrombosis [DVT]) events) occurred within 6 months of surgery, clustered in patients aged between 41 and 60 years and evenly distributed by sex. Cerebral venous thrombosis (CVT) was not observed. In the systematic review, the VTE incidence rate was 6.2%–31% in grade 4 gliomas and 1.4%–5.2% in grades 2 and 3. DVT comprised 60% of thromboembolic events; PTE, 35%; and CVT, 5%. Poor performance status, a surgery duration of > 4 h, and bevacizumab exposure increased the risk for VTE, whereas IDH mutation reduced it by ~ 70%. The median time from surgery to VTE diagnosis was 21–90 days, and 30-day mortality after VTE was 7%–15%. Findings show that large, prospective, multicenter, molecularly annotated glioma cohorts remain vital for thrombosis risk stratification and targeted prophylactic strategy development. Clinical trial number: Not applicable.

  • Open Access

    Abusive head trauma in children under 2 years of age in Latin America: a systematic review

    by José Roberto Tude Melo, Maria Antonia Coladeti Fernandes, Júlia Calviello Giordano, Isabela Zampirolli Leal, Caio Vinicius de Almeida Chaves, José Carlos Esteves Veiga

    Among the types of violence against children, abusive head trauma (AHT) is recognized as one of the main causes of violent death and neurological disabilities in infants. The scope of this systematic review was to examine the scenario and knowledge about AHT in Latin American countries based on studies conducted in Latin America and/or published by Latin American researchers between 2010 and 2024 (15 years). This systematic review was conducted in the PubMed/NIH (National Library of Medicine; National Center for Biotechnology Information), SciELO (Scientific Electronic Library Online), and LILACS (Latin American and Caribbean Literature in Health Sciences) databases. This systematic review was recorded in the Prospective International Registry of Systematic Reviews (PROSPERO CRD42025628791). Among the 462 articles found in the databases, 23 studies were published by Latin American researchers. Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, only 7 articles met the eligibility criteria. Among children with traumatic brain injury, the presence of seizures (70% vs. 46%; p < 0.0001), retinal hemorrhages (78% vs. 3%; p < 0.0001), and subdural hematoma (91% vs. 29%; p < 0.0001) prevailed in suspected or confirmed cases of AHT. There is a shortage of scientific articles on AHT with sufficient sample size to allow us to know the geographic distribution of this event in Latin America. However, Latin American researchers recognize an unwitnessed or incoherent history of trauma along with a lowered level of consciousness, seizures, retinal hemorrhages, and subdural hematoma as strong indicators for suspicion of AHT.

  • Performance and accuracy of blood glucose and neutrophil-lymphocyte ratio as predictors of mortality in children and adolescents with traumatic brain injury

    by José Roberto Tude Melo, Caio Vinicius de Almeida Chaves, Cindy Kawano, Isabela Zampirolli Leal, Maria Antonia Coladeti Fernandes, Stephannie Monaco Bodra, Jean Gonçalves de Oliveira, José Carlos Esteves Veiga

    Purpose Biomarkers are used to establish the diagnosis, staging, and prognosis of diseases. The scope of this study was to assess and compare the performance and accuracy of blood glucose (BG) and neutrophil-lymphocyte ratio (NLR) as predictive biomarkers of mortality in children with traumatic brain injury (TBI). Methods Cross-sectional analytical study through the review of consecutive medical records of children and adolescents (< 17 years) with TBI. The results of blood samples collected in the first 24 h after trauma were reviewed, considering BG ≥ 200 mg/dL or 11.1 mmol/L and NLR ≥ 11 as cutoff points. The receiver operating characteristic (ROC) curve was applied to verify and compare the performance of both biomarkers as predictors of in-hospital mortality. The odds ratio (OR), sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV), accuracy, and likelihood of both biomarkers were calculated. Results Of the 131 children included in the analyses, 13% had hyperglycemia, predominantly those with severe TBI (30% vs. 4%; p = 0003). NLR values ≥ 11 were identified in 21% of the sample, also predominating in children with severe TBI (54% vs. 15%; p = 0.01). The performance of BG and NLR was respectively 0.81 and 0.65 considering the area under the ROC curve. BG presented an accuracy of 88% and NLR of 79% as predictive biomarkers of mortality. Conclusion BG presented better performance and accuracy than NLR, although both biomarkers presented high NPV to identify children at lower risk of death.


  • Open Access

    Characteristics of traumatic brain injury in children and adolescents hospitalized in a Brazilian trauma reference center: a retrospective cross-sectional study

    by José Roberto Tude Melo, Caio Vinicius de Almeida Chaves, Cindy Kawano, Maria Antonia Coladeti Fernandes, Reem Hussin, Jean Gonçalves de Oliveira, José Carlos Esteves Veiga

    Background Approximately 20% of victims of traumatic brain injury (TBI) in Brazil are children and adolescents, with more than 900 deaths per year. Objective To describe the characteristics and epidemiological profile of children and adolescents with TBI in the city of São Paulo, Brazil, according to age groups and metropolitan area of occurrence of the events leading to trauma. Methods We conducted a retrospective cross-sectional study with a review of consecutive medical records of children and adolescents with TBI hospitalized and treated at a level-1 trauma center in São Paulo between 2019 and 2023. Results In the period proposed for the study, 196 children and adolescents suffered TBIs. They had a median age of 5 (interquartile range [IQR] 10–1.75) years and were predominantly boys (71%), of white skin color/race (55%), and coming from the north zone of the metropolitan region of São Paulo (44%). Domestic accidents were the main causes of TBI (61%), followed by traffic accidents (24%). The mean length of hospital stay was of 13 (standard deviation [SD] ± 26) days, and the in-hospital mortality rate was of 3%. Conclusion We found a predominance of children and adolescents with TBI coming from the north zone of the metropolitan region of São Paulo, with a prevalence of falls from heights above the ground among children ≤ 9 years of age and trampling among children older than this age. Preventive actions must be established after reflections on socioeconomic issues and considering the metropolitan area where the accidents occur and the age group.


  • Performance of the neutrophil–lymphocyte ratio as a predictor of severity and mortality in children and adolescents with traumatic brain injury

    by José Roberto Tude Melo, Melina Houlis Hao Masini, Jean Gonçalves de Oliveira, José Carlos Esteves Veiga


  • Accuracy of acute hyperglycemia as a biomarker of severe brain damage in children with traumatic brain injury

    by José Roberto Tude Melo, Chiara Maria de Brito Tischer, Fernanda Paiva Augusto Rodrigues, Júlia Calviello Giordano, Larissa Ferreira Gomes de Oliveira, Stephannie Monaco Bodra, Jean Gonçalves de Oliveira, José Carlos Esteves Veiga

    Purpose Biomarkers are substances measured at the systemic level to evaluate organic responses in certain situations, establishing diagnoses, disease staging, and prognosis. Blood glucose is a biomarker recognized as a predictor of prognosis in children victims of traumatic brain injury (TBI). The scope of this study was to identify the accuracy of blood glucose as a biomarker of severe brain injury. Methods A retrospective analytical study was conducted through the consecutive review of medical records of children and teenage victims of TBI who underwent neurological surgery between 2016 and 2023 in a level 1 trauma center. Two groups were compared: children with Glasgow Coma Scale (GCS) score ≤ 8 and children with GCS > 8. We calculated the predictive values to define the accuracy of blood glucose as a biomarker of brain injury. Results Ninety-two medical records were included for analysis. Hyperglycemia predominated in cases with GCS ≤ 8 (48% vs 3%; p < 0.0001; OR, 30; 95% CI, 5.9902–150.2448). The glycemic measurement considering the cutoff point of 200 mg/dL or 11.1 mmol/L showed a specificity of 97%, a positive predictive value of 86%, an accuracy of 84%, and a likelihood ratio for a positive test of 16. Conclusion Victims with GCS ≤ 8 are 16 times more likely to develop acute hyperglycemia after TBI when compared to those with GCS > 8. Blood glucose is a biomarker with an accuracy of 84% to predict severe brain injury, considering the cutoff point of 200 mg/dL or 11.1 mmol/L.


  • Open Access

    Molecular signature of gliomas correlated to clinical epidemiological aspects of patients in follow-up at a reference center in São Paulo - Brazil - COMU 2023

    by Thaís Tuasca Jareño, Natália Barreto dos Santos, Giovanna Marques Antunes, Catarina Rapôso, José Carlos Esteves Veiga, João Luiz Vitorino Araujo

    We have prepared a manuscript that represents our analysis regarding our study. Gliomas are more than 80% of all primary brain cancers and 24% of all brain tumors 1. In 2021, the new edition of WHO - Classification of Tumors of the Central Nervous System (WHO- CTCNS) 2 established genetic and molecular aspects to the analysis since they could be correlated to characteristics of tumor behavior and clinical-epidemiological features. However, there are few studies correlating molecular analysis to the clinical follow-up of patients in Brazil. We performed a preliminary, observational, prospective and descriptive study that aims to obtain and to compare clinical-epidemiological data to molecular markers of patients in follow-up at Central Hospital of Santa Casa de São Paulo (HC-ISCMSP).